Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
Klinicheskaya Onkogematologiya/Clinical Oncohematology - Russian Federation
doi 10.21320/2500-2139-2016-9-1-48-53
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Practical Medicine Publishing House